Cytek Biosciences, Inc. Common Stock (CTKB) is a publicly traded Healthcare sector company. As of October 21, 2026, CTKB trades at $5.50 with a market cap of $694.11M and a P/E ratio of 0.00. CTKB moved +3.00% today. Year to date, CTKB is +11.79%; over the trailing twelve months it is +31.89%. Its 52-week range spans $2.37 to $6.21. Analyst consensus is buy with an average price target of $5.83. Rallies surfaces CTKB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CTKB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $5.50 |
| Market Cap | $694.11M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.21 |
| 52-Week Low | $2.37 |
| Volume | 932.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $206.71M |
| Net Income | $-80.58M |
| Gross Margin | 53.23% |
3 analysts cover CTKB: 0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.83.